In a letter to integrated care boards and NHS trusts, Sir James Mackey, chief executive officer at NHS England, has outlined expectations for providers on performance and finance for the year ahead, and how the 10 year health plan can be realised. Sir Mackey notes the particular focus on how […]
Author: HTN
Feature: HPCC26 × CRF26 | Sir Jim Mackey to headline europe’s largest patient-centred rare disease, haemato-oncology, research and innovation congress
By Sanius Health Now entering its third year, the Haematology Patient & Carers Congress (HPCC26) and the Clinical Research Forum (CRF26), created and delivered by Sanius Health, have become Europe’s largest events of their kind. Together they draw thousands of participants – senior doctors, patients, policymakers, industry partners, and innovators […]
Trinidad and Tobago’s Eastern Regional Health Authority teams up with Isla Health driving clinical transformation in the Caribbean
Following a successful six-month pilot at Sangre Grande Hospital in Trinidad and Tobago, the eastern regional health authority has decided to roll-out Isla across all services under an ambitious deployment programme. The programme at Sangre Grande Hospital initially focused on three key specialties: wound care, surgical wards, and dietetics, noting […]
HTNLive outline agenda launched!
Connecting digital leaders across health and care through meaningful, focussed, in-depth conversations, HTNLive promises to be an event like no other. HTNLive will pose challenge questions, facilitate discussion and participation, and include in-focus deep dives into digital projects at NHS organisations. We’re pleased to share the outline agenda for HTNLive […]
Feature: Advancing multiple myeloma care; building the future of patient outcomes, research, and support
By Sanius Health Multiple Myeloma (MM) has seen rapid innovation over the past decade. New therapies are extending survival, reshaping treatment pathways, and creating new possibilities for patients. Yet the evidence frameworks we rely on have not kept pace. National datasets record admissions and prescriptions, but they are silent on […]
Feature: From transactions to ongoing dialogue: Rethinking digital engagement, and what the NHS can learn from ParkRun
By Jack Tabner, Accurx For the past two decades, the NHS has been chasing the promise of digital “patient engagement.” Portals, apps, and online services have multiplied, each offering patients the ability to manage appointments, view test results and access their health information. Online surveys and MS Teams focus groups […]
Join HTN for 16 webinars and HTNLive Leeds in 2025
We’ve got a packed calendar from now until December, with 16 webinars covering a range of topics include primary care, EPRs, clinical safety, interoperability, AI in practice, future innovations, ambient scribes and more! Each discussion will see experts from across health and care sharing their detailed insights into various topics, […]
Patients Know Best live in Germany to transform mental health care
A new psychiatric care network in Essen in Germany, is reshaping how mental health services are delivered by utilising the digital platform Patients Know Best (PKB). Currently, the network in Essen and surroundings with psychiatry, resident psychiatrists, psychotherapists, sociotherapists and outpatient psychiatric care are now live on the PKB platform, […]
First team of fantastic speakers leading the agenda for HTNLive announced
Promising to be an event like no other, HTNLive will pose challenge questions, facilitate discussion and participation, and include in-focus deep dives into digital projects at NHS organisations. We’re pleased to share the plan for the day and a team of fantastic people leading the agenda for HTNLive sponsored by […]
Feature: From breakthrough to bedside: closing the myeloma delivery gap in the NHS
Feature: From breakthrough to bedside: closing the myeloma delivery gap in the NHS 24 July, 2025 The treatment landscape for multiple myeloma is changing fast, and for the better. For patients who have relapsed or exhausted their options, there is now a renewed sense of hope. Chimeric Antigen Receptor Therapies […]
